Tag: process

AB “Ignitis grupė” (hereinafter – the Group) informs that on 4 July 2025, the Ministry of Finance of the Republic of Lithuania, which exercises the rights of the majority shareholder, announced the selection of six independent members of the Group’s Supervisory Board. This follows the upcoming end of the current Supervisory Board’s term of office on 25 October 2025. Candidates may apply until 24 July 2025 (inclusive).

AB “Ignitis grupė” (hereinafter – the Group) informs that on 4 July 2025, the Ministry of Finance of the Republic of Lithuania, which exercises the rights of the majority shareholder, announced the selection of six independent members of the Group’s Supervisory Board. This follows the upcoming end of the current Supervisory Board’s term of office on 25 October 2025. Candidates may apply until 24 July 2025 (inclusive).

Munich, Germany, July 04, 2025 – The Strüngmann Award selection committee today announced that Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D., the founders of Araris Biotech, have been honored as this year’s winners. The award aims to support outstanding entrepreneurial and scientific achievements, as well as ground-breaking ideas in the life sciences industry. Araris Biotech’s founding team distinguished itself not only by developing of a novel technology in the antibody-drug conjugates (ADCs) field, but also by successfully validating this innovation through partnerships and a preclinical exit. This new drug class has the potential to significantly advance the development of targeted cancer therapies, thereby delivering added value for people living with cancer worldwide.

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

Honest Loans offers access to flexible online loan connections in 2025, supporting fast funding options for borrowers with less-than-perfect credit.

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2025 (the “Grant Date”), ORIC granted a total of 9,000 non-qualified stock options and 1,600 restricted stock units to one new non-executive employee who began their employment with ORIC in June 2025.